DeepL Large-Scale Enterprise Deployment at Daiichi Sankyo

Title

DeepL Large-Scale Enterprise Deployment at Daiichi Sankyo

Content

DeepL announced the large-scale deployment of DeepL Translate Pro and DeepL Write Pro across Daiichi Sankyo's global pharmaceutical operations beginning March 31, 2025. The implementation leverages DeepL for Enterprise, a specialised enterprise solution designed to address the needs of large organisations deploying AI — offering custom pricing and packaging, advanced personalisation features, enterprise-grade security for business-critical content, and global deployment and management capabilities. Unlike general-purpose AI systems, DeepL's specialised Language AI models are specifically tuned for language, resulting in more precise translations and a reduced risk of hallucinations and misinformation — critical in the pharmaceutical industry where accuracy and contextual nuance are paramount. The deployment is part of Daiichi Sankyo's broader company-wide transformation initiative through advanced digital technologies. DeepL CEO Jaroslaw Kutylowski noted that in an industry operating at the forefront of scientific innovation, pharmaceutical communication demands exceptional precision, clarity, and contextual nuance in every language interaction, and DeepL is uniquely positioned to meet these needs. Over 200,000 businesses worldwide leverage DeepL's platform, and the company reports that its customers achieve significant ROI through improved global collaboration and operational efficiency.

URL